Brookline, MA, United States of America

Jianjun Zhao

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianjun Zhao. Retrieved from https://idiyas.com/inventor/jianjun-zhao-hwtxm7xv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jianjun Zhao

Introduction

Jianjun Zhao is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of hematological malignancies. His work focuses on innovative methods that enhance the effectiveness of therapies for conditions such as multiple myeloma.

Latest Patents

Jianjun Zhao holds a patent titled "Composition and method for treating a hematological malignancy." This patent provides compositions and methods for treating hematological malignancies by increasing levels or activity of miR-30 RNA in plasma cells of the subject. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Zhao is affiliated with the Dana-Farber Cancer Institute Inc., where he conducts research aimed at improving treatment outcomes for patients with blood cancers. His work is characterized by a dedication to understanding the molecular mechanisms underlying these diseases and developing targeted therapies.

Collaborations

Jianjun Zhao collaborates with various professionals in his field, including his coworker Ruben Carrasco. These partnerships enhance the research efforts at the Dana-Farber Cancer Institute and contribute to the advancement of cancer treatment methodologies.

Conclusion

Jianjun Zhao's innovative work in the treatment of hematological malignancies exemplifies the impact of dedicated research in the medical field. His contributions are paving the way for more effective therapies and improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…